HEADER VIRAL PROTEIN/IMMUNE SYSTEM 25-NOV-00 1G9N TITLE HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED TITLE 2 NEUTRALIZING ANTIBODY 17B CAVEAT 1G9N NAG G 588 HAS WRONG CHIRALITY AT ATOM C1 NAG G 741 HAS WRONG CAVEAT 2 1G9N CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENVELOPE GLYCOPROTEIN GP120; COMPND 3 CHAIN: G; COMPND 4 FRAGMENT: CORE; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: T-CELL SURFACE GLYCOPROTEIN CD4; COMPND 9 CHAIN: C; COMPND 10 FRAGMENT: D1D2, N-TERMINAL TWO DOMAIN FRAGMENT; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: ANTIBODY 17B, LIGHT CHAIN; COMPND 15 CHAIN: L; COMPND 16 FRAGMENT: ANTIGEN-BINDING FRAGMENT, FAB; COMPND 17 ENGINEERED: YES; COMPND 18 MOL_ID: 4; COMPND 19 MOLECULE: ANTIBODY 17B, HEAVY CHAIN; COMPND 20 CHAIN: H; COMPND 21 FRAGMENT: ANTIGEN-BINDING FRAGMENT, FAB; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: CLADE B; SOURCE 5 VARIANT: PRIMARY ISOLATE YU2; SOURCE 6 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 9 OTHER_DETAILS: SECRETED FROM DROSOPHILA SCHNEIDER 2 LINES UNDER SOURCE 10 CONTROL OF AN INDUCIBLE METALL OTHIONEIN PROMOTER; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 16 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 18 EXPRESSION_SYSTEM_CELL: OVARY CELLS (CHO); SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 24 EXPRESSION_SYSTEM_COMMON: HOUSE MOUSE; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 26 OTHER_DETAILS: EPSTEIN-BARR VIRUS IMMORTALIZED B-CELL CLONE FUSED SOURCE 27 WITH A MURINE B-CELL FUSION PARTNER; SOURCE 28 MOL_ID: 4; SOURCE 29 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 30 ORGANISM_COMMON: HUMAN; SOURCE 31 ORGANISM_TAXID: 9606; SOURCE 32 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 33 EXPRESSION_SYSTEM_COMMON: HOUSE MOUSE; SOURCE 34 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 35 OTHER_DETAILS: EPSTEIN-BARR VIRUS IMMORTALIZED B-CELL CLONE FUSED SOURCE 36 WITH A MURINE B-CELL FUSION PARTNER KEYWDS COMPLEX (HIV ENVELOPE PROTEIN-CD4-FAB), HIV-1 EXTERIOR ENVELOPE GP120 KEYWDS 2 FROM CLINICAL PRIMARY ISOLATE, YU2, T-CELL SURFACE GLYCOPROTEIN CD4, KEYWDS 3 ANTIGEN-BINDING FRAGMENT OF HUMAN IMMUNOGLOBULIN 17B, VIRAL PROTEIN- KEYWDS 4 IMMUNE SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.D.KWONG,R.WYATT,S.MAJEED,J.ROBINSON,R.W.SWEET,J.SODROSKI, AUTHOR 2 W.A.HENDRICKSON REVDAT 7 09-AUG-23 1G9N 1 REMARK REVDAT 6 27-OCT-21 1G9N 1 REMARK SEQADV HETSYN REVDAT 5 29-JUL-20 1G9N 1 CAVEAT COMPND REMARK HET REVDAT 5 2 1 HETNAM FORMUL LINK SITE REVDAT 5 3 1 ATOM REVDAT 4 02-AUG-17 1G9N 1 SOURCE REMARK REVDAT 3 13-JUL-11 1G9N 1 VERSN REVDAT 2 24-FEB-09 1G9N 1 VERSN REVDAT 1 27-DEC-00 1G9N 0 JRNL AUTH P.D.KWONG,R.WYATT,S.MAJEED,J.ROBINSON,R.W.SWEET,J.SODROSKI, JRNL AUTH 2 W.A.HENDRICKSON JRNL TITL STRUCTURES OF HIV-1 GP120 ENVELOPE GLYCOPROTEINS FROM JRNL TITL 2 LABORATORY-ADAPTED AND PRIMARY ISOLATES. JRNL REF STRUCTURE FOLD.DES. V. 8 1329 2000 JRNL REFN ISSN 0969-2126 JRNL PMID 11188697 JRNL DOI 10.1016/S0969-2126(00)00547-5 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.D.KWONG,R.WYATT,J.ROBINSON,R.W.SWEET,J.SODROSKI, REMARK 1 AUTH 2 W.A.HENDRICKSON REMARK 1 TITL STRUCTURE OF AN HIV GP120 ENVELOPE GLYCOPROTEIN IN COMPLEX REMARK 1 TITL 2 WITH THE CD4 RECEPTOR AND A NEUTRALIZING HUMAN ANTIBODY REMARK 1 REF NATURE V. 393 648 1998 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/31405 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 23030 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1160 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 23 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.94 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 907 REMARK 3 BIN R VALUE (WORKING SET) : 0.3340 REMARK 3 BIN FREE R VALUE : 0.3937 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.51 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 56 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.053 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7173 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 196 REMARK 3 SOLVENT ATOMS : 345 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 60.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 68.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.42600 REMARK 3 B22 (A**2) : 8.51600 REMARK 3 B33 (A**2) : -13.94100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.51 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.63 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.138 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.568 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.820 ; 2.500 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.738 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.860 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.22 REMARK 3 BSOL : 14.44 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS-PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CNS-WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CNS-ION.PARAM REMARK 3 PARAMETER FILE 4 : CNS-CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : CNS-PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CNS-WATER.TOP REMARK 3 TOPOLOGY FILE 3 : CNS-ION.TOP REMARK 3 TOPOLOGY FILE 4 : CNS-CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: OVERALL ANISOTROPIC B VALUE CORRECTION REMARK 3 APPLIED TO DATA DURING CNS REFINEMENT REMARK 4 REMARK 4 1G9N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-DEC-00. REMARK 100 THE DEPOSITION ID IS D_1000012406. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-APR-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9721 REMARK 200 MONOCHROMATOR : SILICON CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23464 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 4.370 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : 0.09300 REMARK 200 FOR THE DATA SET : 10.3800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.43900 REMARK 200 R SYM FOR SHELL (I) : 0.43900 REMARK 200 FOR SHELL : 2.330 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1G9M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOUR DIFFUSION CRYSTALLIZATION: 0.5 REMARK 280 UL OF PROTEIN (5 MG/ML IN 0.35 M NACL, 0.005 M TRIS CL PH 7.0) + REMARK 280 0.35 UL OF RESERVOIR (50 UL OF NA ACETATE PH 4.5 + 250 UL OF REMARK 280 HAMPTON CRYSTAL SCREEN REAGENT 18 + 126 UL OF ETHANOL + 292 UL REMARK 280 OF WATER), PH 5.9, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 87.49000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.85500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 87.49000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 40.85500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, C, L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY G 79 REMARK 465 ALA G 80 REMARK 465 ARG G 81 REMARK 465 SER G 82 REMARK 465 GLU G 83 REMARK 465 VAL G 84 REMARK 465 LYS G 85 REMARK 465 ALA C 182 REMARK 465 SER C 183 REMARK 465 ASN C 184 REMARK 465 THR C 185 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP G 230 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN G 94 76.56 -154.85 REMARK 500 SER G 115 -40.34 -137.00 REMARK 500 LEU G 125 86.79 -156.78 REMARK 500 ALA G 129 36.06 -77.45 REMARK 500 PHE G 210 107.74 -49.43 REMARK 500 PRO G 220 -109.17 -64.05 REMARK 500 LYS G 232 95.04 -162.56 REMARK 500 ASN G 241 40.82 -94.52 REMARK 500 PRO G 253 82.32 -51.81 REMARK 500 GLN G 258 -48.16 73.99 REMARK 500 GLU G 267 -76.40 -50.30 REMARK 500 GLU G 268 -105.32 -60.09 REMARK 500 ASN G 276 88.57 178.87 REMARK 500 ASN G 280 10.49 -67.49 REMARK 500 GLN G 344 12.63 -68.33 REMARK 500 GLU G 351 21.11 -79.71 REMARK 500 GLN G 352 -25.48 -152.05 REMARK 500 ASN G 356 46.65 -77.97 REMARK 500 PHE G 376 168.15 172.96 REMARK 500 SER G 387 39.48 -93.17 REMARK 500 THR G 392 51.80 -142.36 REMARK 500 ASP G 395 45.46 -73.59 REMARK 500 THR G 396 -80.30 -148.91 REMARK 500 LYS G 398 -152.30 -118.75 REMARK 500 LEU G 407 55.29 -174.14 REMARK 500 ASN G 409 -80.50 -46.25 REMARK 500 PRO G 417 96.83 -69.62 REMARK 500 GLU G 429 146.02 -176.18 REMARK 500 ILE G 439 -42.54 -146.22 REMARK 500 THR G 455 95.87 -162.07 REMARK 500 ASP G 461 34.79 37.96 REMARK 500 ASN G 463 162.48 -47.08 REMARK 500 THR G 465 55.33 -164.16 REMARK 500 ASP G 474 78.34 -101.49 REMARK 500 MET G 475 -15.20 -37.38 REMARK 500 LYS G 487 114.91 -179.13 REMARK 500 CYS C 16 103.62 -177.41 REMARK 500 SER C 19 -72.14 -51.92 REMARK 500 SER C 23 97.82 -66.88 REMARK 500 LEU C 37 133.06 -172.52 REMARK 500 GLN C 40 54.54 -112.96 REMARK 500 PRO C 48 -4.65 -57.65 REMARK 500 ASN C 52 -72.97 -41.77 REMARK 500 ASP C 53 -7.63 -57.30 REMARK 500 ASP C 56 149.07 178.84 REMARK 500 SER C 57 -151.87 -108.46 REMARK 500 GLN C 64 33.18 -91.12 REMARK 500 PRO C 68 -173.68 -56.82 REMARK 500 LEU C 69 81.62 -155.28 REMARK 500 ASP C 80 -174.19 -178.43 REMARK 500 REMARK 500 THIS ENTRY HAS 118 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1G9M RELATED DB: PDB REMARK 900 1G9M CONTAINS THE SAME TERNARY COMPLEX FROM A LABORATORY-ADAPTED REMARK 900 ISOLATE. DBREF 1G9N G 83 127 UNP P35961 ENV_HV1Y2 82 126 DBREF 1G9N G 195 297 UNP P35961 ENV_HV1Y2 191 293 DBREF 1G9N G 330 492 UNP P35961 ENV_HV1Y2 325 479 DBREF 1G9N C 1 185 UNP P01730 CD4_HUMAN 26 210 DBREF 1G9N L 1 214 PDB 1G9N 1G9N 1 214 DBREF 1G9N H 1 229 PDB 1G9N 1G9N 1 229 SEQADV 1G9N GLY G 79 UNP P35961 CLONING ARTIFACT SEQADV 1G9N ALA G 80 UNP P35961 CLONING ARTIFACT SEQADV 1G9N ARG G 81 UNP P35961 CLONING ARTIFACT SEQADV 1G9N SER G 82 UNP P35961 CLONING ARTIFACT SEQADV 1G9N GLY G 128 UNP P35961 SEE REMARK 999 SEQADV 1G9N ALA G 129 UNP P35961 SEE REMARK 999 SEQADV 1G9N GLY G 194 UNP P35961 SEE REMARK 999 SEQADV 1G9N GLY G 298 UNP P35961 SEE REMARK 999 SEQADV 1G9N ALA G 299 UNP P35961 SEE REMARK 999 SEQADV 1G9N GLY G 329 UNP P35961 SEE REMARK 999 SEQADV 1G9N ASN C 184 UNP P01730 SER 209 ENGINEERED MUTATION SEQADV 1G9N THR C 185 UNP P01730 ILE 210 ENGINEERED MUTATION SEQRES 1 G 313 GLY ALA ARG SER GLU VAL LYS LEU GLU ASN VAL THR GLU SEQRES 2 G 313 ASN PHE ASN MET TRP LYS ASN ASN MET VAL GLU GLN MET SEQRES 3 G 313 HIS GLU ASP ILE ILE SER LEU TRP ASP GLN SER LEU LYS SEQRES 4 G 313 PRO CYS VAL LYS LEU THR PRO LEU CYS VAL GLY ALA GLY SEQRES 5 G 313 SER CYS ASN THR SER VAL ILE THR GLN ALA CYS PRO LYS SEQRES 6 G 313 VAL SER PHE GLU PRO ILE PRO ILE HIS TYR CYS ALA PRO SEQRES 7 G 313 ALA GLY PHE ALA ILE LEU LYS CYS ASN ASP LYS LYS PHE SEQRES 8 G 313 ASN GLY THR GLY PRO CYS THR ASN VAL SER THR VAL GLN SEQRES 9 G 313 CYS THR HIS GLY ILE ARG PRO VAL VAL SER THR GLN LEU SEQRES 10 G 313 LEU LEU ASN GLY SER LEU ALA GLU GLU GLU ILE VAL ILE SEQRES 11 G 313 ARG SER GLU ASN PHE THR ASN ASN ALA LYS THR ILE ILE SEQRES 12 G 313 VAL GLN LEU ASN GLU SER VAL VAL ILE ASN CYS THR GLY SEQRES 13 G 313 ALA GLY HIS CYS ASN LEU SER LYS THR GLN TRP GLU ASN SEQRES 14 G 313 THR LEU GLU GLN ILE ALA ILE LYS LEU LYS GLU GLN PHE SEQRES 15 G 313 GLY ASN ASN LYS THR ILE ILE PHE ASN PRO SER SER GLY SEQRES 16 G 313 GLY ASP PRO GLU ILE VAL THR HIS SER PHE ASN CYS GLY SEQRES 17 G 313 GLY GLU PHE PHE TYR CYS ASN SER THR GLN LEU PHE THR SEQRES 18 G 313 TRP ASN ASP THR ARG LYS LEU ASN ASN THR GLY ARG ASN SEQRES 19 G 313 ILE THR LEU PRO CYS ARG ILE LYS GLN ILE ILE ASN MET SEQRES 20 G 313 TRP GLN GLU VAL GLY LYS ALA MET TYR ALA PRO PRO ILE SEQRES 21 G 313 ARG GLY GLN ILE ARG CYS SER SER ASN ILE THR GLY LEU SEQRES 22 G 313 LEU LEU THR ARG ASP GLY GLY LYS ASP THR ASN GLY THR SEQRES 23 G 313 GLU ILE PHE ARG PRO GLY GLY GLY ASP MET ARG ASP ASN SEQRES 24 G 313 TRP ARG SER GLU LEU TYR LYS TYR LYS VAL VAL LYS ILE SEQRES 25 G 313 GLU SEQRES 1 C 185 LYS LYS VAL VAL LEU GLY LYS LYS GLY ASP THR VAL GLU SEQRES 2 C 185 LEU THR CYS THR ALA SER GLN LYS LYS SER ILE GLN PHE SEQRES 3 C 185 HIS TRP LYS ASN SER ASN GLN ILE LYS ILE LEU GLY ASN SEQRES 4 C 185 GLN GLY SER PHE LEU THR LYS GLY PRO SER LYS LEU ASN SEQRES 5 C 185 ASP ARG ALA ASP SER ARG ARG SER LEU TRP ASP GLN GLY SEQRES 6 C 185 ASN PHE PRO LEU ILE ILE LYS ASN LEU LYS ILE GLU ASP SEQRES 7 C 185 SER ASP THR TYR ILE CYS GLU VAL GLU ASP GLN LYS GLU SEQRES 8 C 185 GLU VAL GLN LEU LEU VAL PHE GLY LEU THR ALA ASN SER SEQRES 9 C 185 ASP THR HIS LEU LEU GLN GLY GLN SER LEU THR LEU THR SEQRES 10 C 185 LEU GLU SER PRO PRO GLY SER SER PRO SER VAL GLN CYS SEQRES 11 C 185 ARG SER PRO ARG GLY LYS ASN ILE GLN GLY GLY LYS THR SEQRES 12 C 185 LEU SER VAL SER GLN LEU GLU LEU GLN ASP SER GLY THR SEQRES 13 C 185 TRP THR CYS THR VAL LEU GLN ASN GLN LYS LYS VAL GLU SEQRES 14 C 185 PHE LYS ILE ASP ILE VAL VAL LEU ALA PHE GLN LYS ALA SEQRES 15 C 185 SER ASN THR SEQRES 1 L 214 GLU LEU GLU LEU THR GLN SER PRO ALA THR LEU SER VAL SEQRES 2 L 214 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 L 214 GLU SER VAL SER SER ASP LEU ALA TRP TYR GLN GLN LYS SEQRES 4 L 214 PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR GLY ALA SER SEQRES 5 L 214 THR ARG ALA THR GLY VAL PRO ALA ARG PHE SER GLY SER SEQRES 6 L 214 GLY SER GLY ALA GLU PHE THR LEU THR ILE SER SER LEU SEQRES 7 L 214 GLN SER GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN TYR SEQRES 8 L 214 ASN ASN TRP PRO PRO ARG TYR THR PHE GLY GLN GLY THR SEQRES 9 L 214 ARG LEU GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL SEQRES 10 L 214 PHE ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY SEQRES 11 L 214 THR ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO SEQRES 12 L 214 ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU SEQRES 13 L 214 GLN SER GLY ASN SER GLN GLU SER VAL THR GLU GLN LYS SEQRES 14 L 214 SER LYS ASP SER THR TYR SER LEU SER SER THR LEU THR SEQRES 15 L 214 LEU SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA SEQRES 16 L 214 CYS GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR SEQRES 17 L 214 LYS SER PHE ASN ARG GLY SEQRES 1 H 229 GLN VAL GLN LEU LEU GLU SER GLY ALA GLU VAL LYS LYS SEQRES 2 H 229 PRO GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 H 229 ASP THR PHE ILE ARG TYR SER PHE THR TRP VAL ARG GLN SEQRES 4 H 229 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY ARG ILE ILE SEQRES 5 H 229 THR ILE LEU ASP VAL ALA HIS TYR ALA PRO HIS LEU GLN SEQRES 6 H 229 GLY ARG VAL THR ILE THR ALA ASP LYS SER THR SER THR SEQRES 7 H 229 VAL TYR LEU GLU LEU ARG ASN LEU ARG SER ASP ASP THR SEQRES 8 H 229 ALA VAL TYR PHE CYS ALA GLY VAL TYR GLU GLY GLU ALA SEQRES 9 H 229 ASP GLU GLY GLU TYR ARG ASN ASN GLY PHE LEU LYS HIS SEQRES 10 H 229 TRP GLY GLN GLY THR LEU VAL THR VAL THR SER ALA SER SEQRES 11 H 229 THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SER SER SEQRES 12 H 229 LYS SER THR SER GLY GLY THR ALA ALA LEU GLY CYS LEU SEQRES 13 H 229 VAL LYS ASP TYR PHE PRO GLN PRO VAL THR VAL SER TRP SEQRES 14 H 229 ASN SER GLY ALA LEU THR SER GLY VAL HIS THR PHE PRO SEQRES 15 H 229 ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SER SEQRES 16 H 229 VAL VAL THR VAL PRO SER SER SER LEU GLY THR GLN THR SEQRES 17 H 229 TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN THR LYS SEQRES 18 H 229 VAL ASP LYS LYS VAL GLU PRO LYS MODRES 1G9N ASN G 295 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 241 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 394 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 262 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 463 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 408 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 197 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 276 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 386 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 88 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 356 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 448 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 289 ASN GLYCOSYLATION SITE MODRES 1G9N ASN G 234 ASN GLYCOSYLATION SITE HET NAG G 588 14 HET NAG G 697 14 HET NAG G 734 14 HET NAG G 741 14 HET NAG G 762 14 HET NAG G 776 14 HET NAG G 789 14 HET NAG G 795 14 HET NAG G 856 14 HET NAG G 886 14 HET NAG G 894 14 HET NAG G 908 14 HET NAG G 948 14 HET NAG G 963 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 5 NAG 14(C8 H15 N O6) FORMUL 19 HOH *345(H2 O) HELIX 1 1 ASN G 98 LEU G 111 1 14 HELIX 2 2 LYS G 335 GLY G 354 1 20 HELIX 3 3 ASP G 368 THR G 373 1 6 HELIX 4 4 MET G 475 TYR G 484 1 10 HELIX 5 5 LEU C 51 ASP C 53 5 3 HELIX 6 6 ARG C 58 ASP C 63 1 6 HELIX 7 7 LYS C 75 SER C 79 5 5 HELIX 8 8 GLN L 79 PHE L 83 5 5 HELIX 9 9 SER L 123 GLY L 130 1 8 HELIX 10 10 THR H 28 ILE H 30 5 3 HELIX 11 11 THR H 53 ASP H 56 5 4 HELIX 12 12 PRO H 62 LEU H 64 5 3 HELIX 13 13 GLU H 103 GLY H 107 5 5 HELIX 14 14 PRO H 200 LEU H 204 5 5 SHEET 1 A 2 GLU G 91 ASN G 94 0 SHEET 2 A 2 THR G 236 CYS G 239 -1 O GLY G 237 N PHE G 93 SHEET 1 B 4 CYS G 196 ILE G 201 0 SHEET 2 B 4 VAL G 120 CYS G 126 -1 N THR G 123 O SER G 199 SHEET 3 B 4 LYS G 432 MET G 434 -1 O LYS G 432 N LEU G 122 SHEET 4 B 4 ILE G 423 ASN G 425 -1 N ILE G 424 O ALA G 433 SHEET 1 C 3 SER G 243 VAL G 245 0 SHEET 2 C 3 PHE G 223 LYS G 227 -1 N ILE G 225 O VAL G 245 SHEET 3 C 3 TYR G 486 LYS G 490 -1 O VAL G 489 N ALA G 224 SHEET 1 D 5 LEU G 259 LEU G 261 0 SHEET 2 D 5 ARG G 444 ARG G 456 -1 O GLY G 451 N LEU G 260 SHEET 3 D 5 ILE G 284 THR G 297 -1 N ILE G 284 O LEU G 454 SHEET 4 D 5 THR G 465 PRO G 470 0 SHEET 5 D 5 THR G 358 PHE G 361 1 N ILE G 360 O PHE G 468 SHEET 1 E 7 VAL G 271 SER G 274 0 SHEET 2 E 7 ILE G 284 THR G 297 -1 O ILE G 285 N ARG G 273 SHEET 3 E 7 ARG G 444 ARG G 456 -1 O LEU G 454 N ILE G 284 SHEET 4 E 7 HIS G 330 SER G 334 0 SHEET 5 E 7 ASN G 413 LYS G 421 -1 O ILE G 414 N LEU G 333 SHEET 6 E 7 GLU G 381 CYS G 385 -1 N PHE G 382 O LYS G 421 SHEET 7 E 7 HIS G 374 CYS G 378 -1 N HIS G 374 O CYS G 385 SHEET 1 F 4 VAL C 3 LYS C 7 0 SHEET 2 F 4 VAL C 93 ALA C 102 1 O LEU C 96 N GLY C 6 SHEET 3 F 4 ASP C 80 VAL C 86 -1 N TYR C 82 O VAL C 93 SHEET 4 F 4 GLN C 89 LYS C 90 -1 O GLN C 89 N VAL C 86 SHEET 1 G 7 LEU C 44 LYS C 46 0 SHEET 2 G 7 LYS C 35 ASN C 39 -1 N GLY C 38 O THR C 45 SHEET 3 G 7 PHE C 26 LYS C 29 -1 N TRP C 28 O ILE C 36 SHEET 4 G 7 ASP C 80 VAL C 86 -1 O GLU C 85 N HIS C 27 SHEET 5 G 7 VAL C 93 ALA C 102 -1 O VAL C 93 N TYR C 82 SHEET 6 G 7 LEU C 114 GLU C 119 -1 O GLU C 119 N GLY C 99 SHEET 7 G 7 THR C 143 VAL C 146 -1 O LEU C 144 N LEU C 116 SHEET 1 H 3 VAL C 12 GLU C 13 0 SHEET 2 H 3 ILE C 70 ILE C 71 -1 O ILE C 71 N VAL C 12 SHEET 3 H 3 ALA C 55 ASP C 56 -1 N ASP C 56 O ILE C 70 SHEET 1 I 2 HIS C 107 LEU C 108 0 SHEET 2 I 2 VAL C 175 VAL C 176 1 O VAL C 175 N LEU C 108 SHEET 1 J 3 GLN C 139 GLY C 140 0 SHEET 2 J 3 SER C 127 GLN C 129 -1 N VAL C 128 O GLY C 140 SHEET 3 J 3 VAL C 161 LEU C 162 -1 O LEU C 162 N SER C 127 SHEET 1 K 2 THR C 156 TRP C 157 0 SHEET 2 K 2 ILE C 172 ASP C 173 -1 O ILE C 172 N TRP C 157 SHEET 1 L 5 THR L 10 VAL L 13 0 SHEET 2 L 5 ARG L 105 ILE L 108 1 O ARG L 105 N LEU L 11 SHEET 3 L 5 ALA L 84 GLN L 90 -1 N ALA L 84 O LEU L 106 SHEET 4 L 5 LEU L 33 GLN L 38 -1 N TYR L 36 O TYR L 87 SHEET 5 L 5 LEU L 46 ILE L 48 -1 O ILE L 48 N TRP L 35 SHEET 1 M 4 THR L 10 VAL L 13 0 SHEET 2 M 4 ARG L 105 ILE L 108 1 O ARG L 105 N LEU L 11 SHEET 3 M 4 ALA L 84 GLN L 90 -1 N ALA L 84 O LEU L 106 SHEET 4 M 4 THR L 99 PHE L 100 -1 O THR L 99 N GLN L 90 SHEET 1 N 3 ARG L 18 ALA L 19 0 SHEET 2 N 3 GLU L 70 SER L 77 -1 O ILE L 75 N ALA L 19 SHEET 3 N 3 SER L 22 ARG L 24 -1 N CYS L 23 O PHE L 71 SHEET 1 O 3 ARG L 18 ALA L 19 0 SHEET 2 O 3 GLU L 70 SER L 77 -1 O ILE L 75 N ALA L 19 SHEET 3 O 3 PHE L 62 GLY L 66 -1 N SER L 63 O THR L 74 SHEET 1 P 3 VAL L 117 PHE L 120 0 SHEET 2 P 3 ALA L 132 PHE L 141 -1 O VAL L 135 N PHE L 120 SHEET 3 P 3 TYR L 175 LEU L 183 -1 O LEU L 183 N ALA L 132 SHEET 1 Q 3 ALA L 146 VAL L 152 0 SHEET 2 Q 3 VAL L 193 HIS L 200 -1 O THR L 199 N LYS L 147 SHEET 3 Q 3 VAL L 207 THR L 208 -1 O VAL L 207 N VAL L 198 SHEET 1 R 3 ALA L 146 VAL L 152 0 SHEET 2 R 3 VAL L 193 HIS L 200 -1 O THR L 199 N LYS L 147 SHEET 3 R 3 PHE L 211 ASN L 212 -1 O PHE L 211 N TYR L 194 SHEET 1 S 4 GLN H 3 GLU H 6 0 SHEET 2 S 4 SER H 17 SER H 25 -1 O SER H 25 N GLN H 3 SHEET 3 S 4 THR H 78 ARG H 84 -1 O LEU H 81 N VAL H 20 SHEET 4 S 4 VAL H 68 ASP H 73 -1 N ASP H 73 O THR H 78 SHEET 1 T 5 ALA H 58 TYR H 60 0 SHEET 2 T 5 LEU H 45 ILE H 51 -1 N ARG H 50 O HIS H 59 SHEET 3 T 5 TYR H 32 GLN H 39 -1 N PHE H 34 O ILE H 51 SHEET 4 T 5 ALA H 92 TYR H 100 -1 O ALA H 97 N THR H 35 SHEET 5 T 5 HIS H 117 TRP H 118 -1 O HIS H 117 N GLY H 98 SHEET 1 U 5 ALA H 58 TYR H 60 0 SHEET 2 U 5 LEU H 45 ILE H 51 -1 N ARG H 50 O HIS H 59 SHEET 3 U 5 TYR H 32 GLN H 39 -1 N PHE H 34 O ILE H 51 SHEET 4 U 5 ALA H 92 TYR H 100 -1 O ALA H 97 N THR H 35 SHEET 5 U 5 THR H 122 VAL H 124 -1 O THR H 122 N TYR H 94 SHEET 1 V 4 PRO H 138 LEU H 139 0 SHEET 2 V 4 ALA H 151 CYS H 155 -1 O GLY H 154 N LEU H 139 SHEET 3 V 4 TYR H 191 VAL H 199 -1 O VAL H 199 N ALA H 151 SHEET 4 V 4 PHE H 181 LEU H 185 -1 N PHE H 181 O SER H 194 SHEET 1 W 3 THR H 166 TRP H 169 0 SHEET 2 W 3 TYR H 209 ASN H 214 -1 O ASN H 212 N SER H 168 SHEET 3 W 3 VAL H 222 VAL H 226 -1 O VAL H 226 N TYR H 209 SSBOND 1 CYS G 119 CYS G 205 1555 1555 2.04 SSBOND 2 CYS G 126 CYS G 196 1555 1555 2.03 SSBOND 3 CYS G 218 CYS G 247 1555 1555 2.04 SSBOND 4 CYS G 228 CYS G 239 1555 1555 2.04 SSBOND 5 CYS G 296 CYS G 331 1555 1555 2.02 SSBOND 6 CYS G 331 CYS G 385 1555 1555 3.00 SSBOND 7 CYS G 378 CYS G 445 1555 1555 2.03 SSBOND 8 CYS G 385 CYS G 418 1555 1555 2.03 SSBOND 9 CYS C 16 CYS C 84 1555 1555 2.04 SSBOND 10 CYS C 130 CYS C 159 1555 1555 2.03 SSBOND 11 CYS L 23 CYS L 88 1555 1555 2.05 SSBOND 12 CYS L 136 CYS L 196 1555 1555 2.03 SSBOND 13 CYS H 22 CYS H 96 1555 1555 2.02 SSBOND 14 CYS H 155 CYS H 211 1555 1555 2.03 LINK ND2 ASN G 88 C1 NAG G 588 1555 1555 1.46 LINK ND2 ASN G 197 C1 NAG G 697 1555 1555 1.45 LINK ND2 ASN G 234 C1 NAG G 734 1555 1555 1.46 LINK ND2 ASN G 241 C1 NAG G 741 1555 1555 1.45 LINK ND2 ASN G 262 C1 NAG G 762 1555 1555 1.45 LINK ND2 ASN G 276 C1 NAG G 776 1555 1555 1.45 LINK ND2 ASN G 289 C1 NAG G 789 1555 1555 1.46 LINK ND2 ASN G 295 C1 NAG G 795 1555 1555 1.44 LINK ND2 ASN G 356 C1 NAG G 856 1555 1555 1.46 LINK ND2 ASN G 386 C1 NAG G 886 1555 1555 1.45 LINK ND2 ASN G 394 C1 NAG G 894 1555 1555 1.45 LINK ND2 ASN G 408 C1 NAG G 908 1555 1555 1.45 LINK ND2 ASN G 448 C1 NAG G 948 1555 1555 1.46 LINK ND2 ASN G 463 C1 NAG G 963 1555 1555 1.45 CISPEP 1 TRP L 94 PRO L 95 0 -0.08 CISPEP 2 TYR L 142 PRO L 143 0 2.86 CISPEP 3 PHE H 161 PRO H 162 0 -0.29 CISPEP 4 GLN H 163 PRO H 164 0 3.64 CRYST1 174.980 81.710 74.480 90.00 90.37 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005715 0.000000 0.000037 0.00000 SCALE2 0.000000 0.012238 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013427 0.00000